We are live on !
Find out more
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.94%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.64B
AUM Growth
+$244M
(+10%)
Cap. Flow
+$55.9M
Cap. Flow % of AUM
Cap. Flow %
2.11%
Top 10 Holdings %
Top 10 Hldgs %
30.38%
Holding
727
New
40
Increased
101
Reduced
241
Closed
72
Avg Time Held
3.7
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Growth ETF
EFG
|
+$38M |
| 2 |
NVIDIA
NVDA
|
+$32.9M |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$31.9M |
| 4 |
Vanguard International Dividend Appreciation ETF
VIGI
|
+$17.1M |
| 5 |
Eli Lilly
LLY
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$12.2M |
| 2 |
PayPal
PYPL
|
+$12.2M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$11.6M |
| 4 |
Adobe
ADBE
|
+$10.7M |
| 5 |
Becton Dickinson
BDX
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Miscellaneous | 15.82% |
| 3 | Financials | 12.86% |
| 4 | Healthcare | 10.67% |
| 5 | Consumer Discretionary | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Avery Dennison
AVY
$14.2B
| $78.1K | ﹤0.01% |
350
-154
| -31% | -$31.9K |
2021 Q1
12 quarters
|
|
377
Texas Pacific Land
TPL
$20.1B
| $78.1K | ﹤0.01% |
405
-10,926
| -96% | -$1.87M |
2020 Q1
16 quarters
|
|
378
Vanguard Real Estate ETF
VNQ
$38.6B
| $76.4K | ﹤0.01% |
883
+162
| +22% | +$13.8K |
2021 Q4
9 quarters
|
|
379
Vanguard US Momentum Factor ETF
VFMO
$1.82B
| $75.6K | ﹤0.01% |
+500
| New | +$70.3K |
2024 Q1
0 quarters
|
|
380
State Street Industrial Select Sector SPDR ETF
XLI
$30.9B
| $75.6K | ﹤0.01% |
600
-400
| -40% | -$47.1K |
2021 Q4
9 quarters
|
|
381
Yum China
YUMC
$17.1B
| $75K | ﹤0.01% |
1,885
| – | – |
2021 Q4
9 quarters
|
|
382
Plains GP Holdings
PAGP
$5.22B
| $74.5K | ﹤0.01% |
4,084
| – | – |
2022 Q1
8 quarters
|
|
383
Stanley Black & Decker
SWK
$16.8B
| $73.4K | ﹤0.01% |
750
| – | – |
2021 Q4
9 quarters
|
|
384
iShares Russell 2000 Value ETF
IWN
$14B
| $73.1K | ﹤0.01% |
+460
| New | +$69.7K |
2024 Q1
0 quarters
|
|
385
Hexcel
HXL
$6.02B
| $72.8K | ﹤0.01% |
1,000
| – | – |
2021 Q4
9 quarters
|
|
386
iShares MSCI Emerging Markets ETF
EEM
$28.2B
| $72.3K | ﹤0.01% |
1,760
-1,038
| -37% | -$41.3K |
2013 Q2
43 quarters
|
|
387
Biogen
BIIB
$37.5B
| $72.2K | ﹤0.01% |
335
| – | – |
2021 Q4
9 quarters
|
|
388
iShares Core MSCI Emerging Markets ETF
IEMG
$146B
| $71.1K | ﹤0.01% |
1,377
-104
| -7% | -$5.21K |
2018 Q1
24 quarters
|
|
389
Toronto Dominion Bank
TD
$202B
| $70K | ﹤0.01% |
1,160
-231
| -17% | -$14K |
2021 Q4
9 quarters
|
|
390
Newmont
NEM
$118B
| $69.6K | ﹤0.01% |
1,942
| – | – |
2021 Q4
9 quarters
|
|
391
iShares S&P 100 ETF
OEF
$19.9B
| $69K | ﹤0.01% |
279
| – | – |
2021 Q1
12 quarters
|
|
392
Gilead Sciences
GILD
$208B
| $68.1K | ﹤0.01% |
930
+55
| +6% | +$4.23K |
2021 Q4
9 quarters
|
|
393
PagerDuty
PD
$1.25B
| $68K | ﹤0.01% |
+3,000
| New | +$71.2K |
2024 Q1
0 quarters
|
|
394
McCormick & Company Non-Voting
MKC
$12.6B
| $67.9K | ﹤0.01% |
884
| – | – |
2021 Q4
9 quarters
|
|
395
Everspin Technologies
MRAM
$299M
| $66.5K | ﹤0.01% |
8,400
| – | – |
2021 Q4
9 quarters
|
|
396
Vanguard Morningstar Small-Cap ETF
VB
$79B
| $66.5K | ﹤0.01% |
291
| – | – |
2020 Q3
14 quarters
|
|
397
Fabrinet
FN
$11.7B
| $66.2K | ﹤0.01% |
350
| – | – |
2021 Q4
9 quarters
|
|
398
Fiserv Inc
FISV
$33.9B
| $64.2K | ﹤0.01% |
402
| – | – |
2021 Q4
9 quarters
|
|
399
Bank of New York Mellon
BNY
$103B
| $63.4K | ﹤0.01% |
1,100
| – | – |
2020 Q2
15 quarters
|
|
400
Roper Technologies
ROP
$47.5B
| $62.8K | ﹤0.01% |
112
-56
| -33% | -$30.6K |
2020 Q2
15 quarters
|
|
Similar funds
Cambridge Trust's Q1 2024 Portfolio in Review
As of Q1 2024, Cambridge Trust held 727 positions worth $2.64B, up 10% from $2.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Cambridge Trust's Q1 2024 filing shows 40 new, 101 increased, 241 reduced and 72 closed positions. Its largest new stake was Best Buy: 93,973 shares worth $7.71M. The largest sale was JPMorgan Equity Premium Income ETF, an estimated $12.2M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Miscellaneous and Financials.
- Cambridge Trust's largest Q1 2024 buy was Best Buy: 93,973 shares worth $7.71M.
- Cambridge Trust added most to iShares MSCI EAFE Growth ETF in Q1 2024, an estimated $38M increase.
- Cambridge Trust's biggest Q1 2024 reduction was JPMorgan Equity Premium Income ETF, cutting an estimated $12.2M.
- Cambridge Trust fully exited Marvell Technology in Q1 2024, selling an estimated $302K.
- Cambridge Trust's ten largest holdings make up 30% of its $2.64B portfolio in Q1 2024.
- Cambridge Trust opened 40 new positions and closed 72 in Q1 2024.
- Cambridge Trust's portfolio value rose 10% quarter-over-quarter to $2.64B.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.